Search results

Page results

• Cystic fibrosis drug tested to fight inflammation in COVID-19

  Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.

• UCLH top acute teaching trust in new national rankings

  We’re proud that UCLH is ranked number one of all acute teaching trusts in new national league tables published today.

• Increase in delirium, rare brain inflammation and stroke linked to COVID-19

  Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.

• New national study on long-term health impacts of COVID-19 launched

  UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.

• Getting Ready for Transition (GReaT) to secondary school

  Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Tuesday 31 January 2023. 

• Single-dose radiotherapy as effective for treating breast cancer, long-term study finds

  A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.

• Millions of men could benefit from faster scan to diagnose prostate cancer

  A quicker, cheaper MRI scan is just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, according to clinical trial results led by UCLH, UCL and the University of Birmingham.

• Loss of smell a ‘highly specific’ indicator of Covid-19, finds UCLH and UCL research

  Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.

• Age no criterion for decisions on heart attack treatment, new research finds

  Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.

• Covid-19 NHS vaccination centre opens at London’s Business Design Centre

  London’s Business Design Centre opens its doors this week as a large- scale COVID-19 vaccination facility.